TNGX

Tango Therapeutics, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1819133Held by 6 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

6 managers · Q2 2026 13F

13F bookWeight

Vivo Capital

Vivo CapitalPosition history →

3.9%

(36.0%)

$43.1M

$1.10B13F book · 2026-06-30

Deerfield Management Company

Deerfield Management CompanyPosition history →

1.4%

+1.1%

$131.0M

$9.59B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.25%

(56.3%)

$175.1M

$71.32B13F book · 2026-06-30

Holocene Advisors

Holocene AdvisorsPosition history →

0.17%

(38.7%)

$75.4M

$43.69B13F book · 2026-06-30

Baker Bros. Advisors

Baker Bros. AdvisorsPosition history →

0.05%

NEW

$10.4M

$19.96B13F book · 2026-06-30

Renaissance Technologies

Renaissance TechnologiesPosition history →

0.03%

NEW

$23.4M

$72.62B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.